How Does the Market View Chewy?

This afternoon we watched Chewy rise 2.7% to a price of $33.91 per share. The large-cap Specialty Retail company is now trading -24.56% below its average target price of $44.95. Analysts have set target prices ranging from $24.0 to $67.75 per share for Chewy, and have given the stock an average rating of buy.

The stock has an unusually large proportion of its shares sold short at 36.3%, and a short ratio of 6.19. The company's insiders own 17.52% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 96.1% of Chewy's shares being owned by this investor type.

Institutions Invested in Chewy

Date Reported Holder Percentage Shares Value
2022-12-31 Morgan Stanley 18% 20,287,240 $687,940,305
2023-03-31 Baillie Gifford and Company 14% 16,528,678 $560,487,468
2022-12-31 Vanguard Group, Inc. (The) 7% 7,619,549 $258,378,905
2023-03-31 Brown Advisory Inc. 6% 6,711,811 $227,597,509
2022-12-31 Wellington Management Group, LLP 4% 5,097,740 $172,864,362
2022-12-31 Goldman Sachs Group Inc 2% 2,601,774 $88,226,155
2022-12-31 Marshall Wace LLP 2% 2,587,868 $87,754,603
2022-12-31 Macquarie Group Limited 2% 2,483,705 $84,222,436
2022-12-31 Blackrock Inc. 2% 2,467,898 $83,686,420
2022-12-31 BC Partners Advisors L.P. 0% 311,852,395 $10,574,914,666

Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Chewy.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.